Literature DB >> 17546014

Imaging mass spectrometry at cellular length scales.

A F Maarten Altelaar1, Stefan L Luxembourg, Liam A McDonnell, Sander R Piersma, Ron M A Heeren.   

Abstract

Imaging mass spectrometry (IMS) allows the direct investigation of both the identity and the spatial distribution of the molecular content directly in tissue sections, single cells and many other biological surfaces. In this protocol, we present the steps required to retrieve the molecular information from tissue sections using matrix-enhanced (ME) and metal-assisted (MetA) secondary ion mass spectrometry (SIMS) as well as matrix-assisted laser desorption/ionization (MALDI) IMS. These techniques require specific sample preparation steps directed at optimal signal intensity with minimal redistribution or modification of the sample analytes. After careful sample preparation, different IMS methods offer a unique discovery tool in, for example, the investigation of (i) drug transport and uptake, (ii) biological processing steps and (iii) biomarker distributions. To extract the relevant information from the huge datasets produced by IMS, new bioinformatics approaches have been developed. The duration of the protocol is highly dependent on sample size and technique used, but on average takes approximately 5 h.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17546014     DOI: 10.1038/nprot.2007.117

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  31 in total

1.  Data processing for 3D mass spectrometry imaging.

Authors:  Xingchuang Xiong; Wei Xu; Livia S Eberlin; Justin M Wiseman; Xiang Fang; You Jiang; Zejian Huang; Yukui Zhang; R Graham Cooks; Zheng Ouyang
Journal:  J Am Soc Mass Spectrom       Date:  2012-03-03       Impact factor: 3.109

2.  Digital imaging mass spectrometry.

Authors:  Casimir Bamberger; Uwe Renz; Andreas Bamberger
Journal:  J Am Soc Mass Spectrom       Date:  2011-04-12       Impact factor: 3.109

Review 3.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  3D imaging by mass spectrometry: a new frontier.

Authors:  Erin H Seeley; Richard M Caprioli
Journal:  Anal Chem       Date:  2012-02-16       Impact factor: 6.986

5.  Fiducial markers for combined 3-dimensional mass spectrometric and optical tissue imaging.

Authors:  Kamila Chughtai; Lu Jiang; Tiffany R Greenwood; Ivo Klinkert; Erika R Amstalden van Hove; Ron M A Heeren; Kristine Glunde
Journal:  Anal Chem       Date:  2012-02-07       Impact factor: 6.986

6.  Automated, feature-based image alignment for high-resolution imaging mass spectrometry of large biological samples.

Authors:  Alexander Broersen; Robert van Liere; A F Maarten Altelaar; Ron M A Heeren; Liam A McDonnell
Journal:  J Am Soc Mass Spectrom       Date:  2008-03-18       Impact factor: 3.109

7.  Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models.

Authors:  Erika R Amstalden van Hove; Tiffany R Blackwell; Ivo Klinkert; Gert B Eijkel; Ron M A Heeren; Kristine Glunde
Journal:  Cancer Res       Date:  2010-11-02       Impact factor: 12.701

Review 8.  Heterogeneities of individual catalyst particles in space and time as monitored by spectroscopy.

Authors:  Inge L C Buurmans; Bert M Weckhuysen
Journal:  Nat Chem       Date:  2012-10-23       Impact factor: 24.427

9.  Biomolecular imaging with a C60-SIMS/MALDI dual ion source hybrid mass spectrometer: instrumentation, matrix enhancement, and single cell analysis.

Authors:  Eric J Lanni; Sage J B Dunham; Peter Nemes; Stanislav S Rubakhin; Jonathan V Sweedler
Journal:  J Am Soc Mass Spectrom       Date:  2014-09-03       Impact factor: 3.109

Review 10.  Qualitative and quantitative mass spectrometry imaging of drugs and metabolites.

Authors:  Christopher B Lietz; Erin Gemperline; Lingjun Li
Journal:  Adv Drug Deliv Rev       Date:  2013-04-18       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.